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Abstract Purpose: To assess the
value of F-18-ﬂuorodeoxyglucose
positron emission tomography (FDG-
PET) combined with CT in critically
ill patients suspected of having an
infection. Methods: FDG-PET CT
scans requested for evaluation of a
suspected infection or inﬂammatory
process in critically ill, mechanically
ventilated patients were analyzed
(blinded for the ﬁnal clinical diagno-
sis) and compared with clinical
follow-up. Results: Thirty-ﬁve
FDG-PET/CT scans performed in
33 ICU patients (28 adults and 5
children), median age 58 years
(range 1 month–72 years), were
analyzed. Twenty-one FDG-PET/CT
scans were true positive. Three
FDG-PET/CT scans were considered
false positive, in one case leading to
additional diagnostic procedures
(speciﬁcity 79%). Additionally, 11
true negatives were found (sensitivity
100%), leading to an overall accuracy
of 91%. Conclusions: FDG-PET/
CT scanning is of additional value in
the evaluation of suspected infection
in critically ill patients in whom
conventional diagnostics did not lead
to a diagnosis. Apart from the high
accuracy, in this study it appeared
that, in addition to conventional
diagnostic techniques that were
routinely performed, a normal
FDG-PET/CT ruled out important
infections requiring prolonged anti-
biotic therapy or drainage. Since
sensitivity is lower in highly meta-
bolic active tissues (e.g., endocarditis,
meningitis), the FDG-PET/CT scan is
not suited to detect infections in these
tissues.
Keywords Positron emission
tomography  Critical illness 
Intensive care  Infection  Diagnosis
Introduction
At some point in time during their stay in the ICU, many
critically ill patients are suspected of having an infectious
process.Whileinmostcases,adiagnosiscanbereachedon
clinical, radiological or microbiological grounds, a sig-
niﬁcant number of cases remain in which a deﬁnitive
diagnosis cannot be made even following extensive
diagnostictesting.Timelyidentiﬁcationandlocalizationof
infectious foci is critical for appropriate treatment of these
patients. However, given the limitations and side effects of
conventional diagnostic procedures (e.g., excessive radia-
tion exposure, contrast nephrotoxicity), new techniques to
detect these infectious foci are still necessary.
In recent years, F-18-ﬂuorodeoxyglucose (FDG) posi-
tron emission tomography (PET) scanning has gained
Intensive Care Med (2010) 36:504–511
DOI 10.1007/s00134-009-1697-8 ORIGINALinterest. FDG-PET depicts cells with an enhanced glucose
metabolism. Apart from its role in the evaluation of
malignancies, the role of FDG-PET in the diagnosis of
focal inﬂammation and infection has been studied in
patients suffering from osteomyelitis [1–3], vasculitis [4–
8], inﬂammatory bowel disease [9–11] and sarcoidosis
[12, 13]. Moreover, recent studies have shown its useful-
ness as a diagnostic tool in patients with fever of unknown
origin (FUO) where more than one third of the PET scans
were considered helpful in reaching a ﬁnal diagnosis [14–
17]. In a retrospective study evaluating FDG-PET scan-
ning in patients with bacteremia suspected of metastatic
infectious complications, FDG-PET revealed clinically
relevant new infectious foci in 45% of patients with a
negative predictive value of 100% [18]. Importantly, in all
of these studies, patients admitted to an ICU were exclu-
ded. To our knowledge, up to now the role of FDG-PET in
diagnosing focal infections in the critically ill ICU patient
has not been evaluated systematically.
To assess the role of FDG-PET for the evaluation of
ventilated critically ill patients with suspected infection or
inﬂammation, we evaluated the results of FDG-PET in
this speciﬁc group of patients. By using an integrated
PET/CT scanner, the functional (PET) and anatomical
(CT) images were recorded in one session, providing
direct correlation between areas of increased FDG uptake
and anatomical changes in a single diagnostic procedure.
Methods
Patients
Between October 2005 and March 2008, all FDG-PET/CT
scans ordered for evaluation of a suspected infection in
mechanically ventilated ICU patients in a 34-bed medical
and surgical ICU were analyzed. Following Dutch law,
approval by an ethics committee was exempt since PET/
CT scans are frequently made in our hospital in the
workup of patients with FUO, and the described results
should be considered as a retrospective observational
study. Only FDG-PET/CT scans were included of patients
in whom a clear clinical suspicion of infection existed,
indicated by at least one of the following signs: fever,
leucocytosis ([12 9 10
9/l), tachycardia ([90 bpm), ele-
vated levels of C-reactive protein ([100 mg/l), positive
blood cultures and/or persistent vasopressor dependency.
A ﬁxed diagnostic protocol prior to the PET/CT scan was
not obligatory; however, all patients underwent an exten-
sive physical examination, laboratory investigation,
culturing and chest X-ray. In most of the patients, addi-
tional diagnostic procedures (CT scanning, abdominal
ultrasound, echocardiography) were performed prior to the
FDG-PET/CT scan. For pragmatic reasons no selection
was made based on type of suspected infection, so all ICU
patients with the above-mentioned criteria were included.
FDG-PET/CT
An integrated PET/CT scanner (Siemens Biograph,
Knoxville, TN) was used for data acquisition. Prior to
FDG injection, patients were fasted, and glucose or
insulin-containing intravenous infusions were discontin-
ued for at least 6 h. In all patients, glucose levels were
checked and were below 11 mmol/l. One hour after
intravenous injection of 200–220 MBq FDG (Covidien,
Petten, The Netherlands), a low-dose CT of the area
between the proximal femora and the base of the skull
was made for anatomical correlation and attenuation
correction of the PET data.
Subsequently, emission images of the same area were
acquired, using an emission time of 4 min per bed posi-
tion. The FDG dose was based on the patient’s weight
according to the NEDPAS guidelines [19]. Immediately
after performing the FDG-PET/CT scan, the results were
interpreted by two staff members of the Department of
Nuclear Medicine without knowledge of the results of
other diagnostic tests or the ﬁnal diagnosis. Disagree-
ments were resolved by consensus.
Interpretation of FDG-PET/CT scan results
The ﬁnal diagnosis, based on biopsy, positive serology,
positive cultures or autopsy results, was used for com-
parison with FDG-PET/CT results. This diagnosis was
made by the ICU staff responsible for the treatment of the
patient with knowledge of the results of the FDG-PET/CT
scan. The diagnosis was never based on the results of the
FDG-PET/CT scan alone.
Abnormal FDG-PET/CT scans were considered help-
ful in establishing the diagnosis or ‘true positive’ when
abnormal FDG-uptake in an organ or tissue corresponded
with the site of infection/inﬂammation as determined by
additional diagnostic techniques. Abnormal results were
regarded as non-contributory to diagnosis or ‘false posi-
tive’ when the detected abnormality was considered to be
unrelated to the illness causing the inﬂammatory response
or when no ﬁnal diagnosis could be made. A normal
FDG-PET/CT scan was considered ‘true negative’ when
no cause of the symptoms was identiﬁed despite an
extensive diagnostic workup and clinical follow-up until
ICU discharge or death. As FDG-PET is unsuitable for
detection of infectious foci within the brain, the heart and
kidney due to high physiological FDG uptake, FDG-PET
was not evaluated for infectious foci in these organs.
When patients were discharged and readmitted to the
ICU, the clinical course until the second discharge was
recorded. Infections diagnosed more than 2 weeks after
FDG-PET/CT were not considered to be present at the
time of FDG-PET/CT. A normal FDG-PET scan was
considered ‘false negative’ when a focal infection, a focal
inﬂammatory process or neoplasm that reasonably can be
505detected with PET/CT scanning was diagnosed by means
of tissue cultures or histology that was thought to be
already present at the time of the FDG-PET/CT scan.
Statistical analysis
We calculated sensitivity, speciﬁcity, positive and nega-
tive predictive values, positive and negative likelihood
ratios and the overall accuracy deﬁned as true posi-
tives ? true negatives/true positives ? true negatives ?
false positives ? false negatives.
Results
From October 2005 to March 2008, 38 FDG-PET/CT
scans were performed in 36 ICU patients. There were
4,180 ICU admissions during this period. No adverse
effects were observed after injection of the tracer. No
complications occurred during transport to and from the
PET/CT scanner. One patient did not fulﬁll the criteria
and was therefore excluded. Two patients were excluded
because of a very short follow-up time of 1 day during
which no deﬁnitive diagnosis was made; 1 patient died
and 1 patient was transferred to the ward, so the results of
35 FDG-PET/CT scans performed in 33 patients were
analyzed (28 adults and 5 children, 24 male and 9 female)
with a median age of 58 years (range 1 month–72 years).
In two patients, a second FDG-PET/CT scan was ordered.
These were considered to be separate cases since the time
interval between these PET/CT scans was at least
1 month.
ICU admission diagnoses of patients are illustrated in
Table 1. Reasons for FDG-PET/CT scanning were per-
sistent fever (n = 17), suspected septic emboli (n = 10),
suspected mediastinitis (n = 3), persistent systemic
inﬂammatory response syndrome (SIRS) (n = 3) and
suspicion of infected intra-abdominal ﬂuid collections
(n = 2). In 27 of 35 cases antibiotic (n = 24) and/or
antifungal (n = 3) treatment was given, and in 30 cases,
fever was present at the time of the FDG-PET/CT scan
with a median duration of 12 days (range 2–41 days).
Table 2 shows the prior diagnostic workup, the
deﬁnite clinical diagnosis and the correlation with the
PET/CT scan results of all included patients. Of 35 FDG-
PET/CT scans, 24 were considered abnormal, and 11
were considered normal. Of the 24 abnormal FDG-PET/
CT scans, 21 were considered true positive (Table 3). In
14 of these 21 true positives, additional investigations
were performed to evaluate the PET/CT abnormalities
(radiologic imaging n = 7, consulting a specialist n = 4,
additional culturing n = 3). In ﬁve cases, the results of
the PET/CT scan had direct therapeutic consequences
(surgery n = 3; removal of i.v. cannula n = 1; start of
antibiotic therapy n = 1). Figures 1 and 2 illustrate two
cases in which the results of the FDG-PET/CT scans
showed unexpected abnormalities where subsequent
diagnostic tests indeed showed an infection at the site of
those abnormalities. True-positive FDG-PET results were
ultimately conﬁrmed by culture (n = 12), biopsy (n = 2)
or autopsy (n = 1), and a probable conﬁrmation was
reached in six cases through radiology (n = 5) or clinical
improvement after treatment based on the FDG-PET/CT
scan results (n = 1; Table 4) described in the electronic
supplement.
In 11 patients in whom additional investigations and
the clinical course showed no evidence of an infection, a
normal FDG-PET/CT scan was classiﬁed as ‘true nega-
tive.’ In one case, a patient, transferred from another ICU
because of difﬁcult weaning after a pneumococcal pneu-
monia, a FDG-PET/CT scan was made because of
persisting fever, showing no clear abnormalities. Since
the presence of an autoimmune systemic disease was
suspected, additional diagnostic tests were performed,
including a kidney biopsy, and a ﬁnal diagnosis of
systemic lupus erythematodes was made. Although the
auto-immune inﬂammatory disease was not detected by
FDG-PET/CT scan, this patient had no active infection, so
he was evaluated as being true negative for infection.
In those patients in whom the FDG-PET/CT scan
results were negative, median duration of clinical follow-
up was 33 days (range 4–74 days). After ICU discharge,
hospital correspondence was reviewed with a median
duration of 5 months (range 1–12) after discharge off the
ICU.
In three patients, positive results of the FDG-PET/CT
scan were followed by several diagnostic tests, which
ﬁnally showed no abnormalities and were consequently
termed ‘false positive.’ In one patient, admitted with an
infective endocarditis, a FDG-PET/CT scan, performed to
Table 1 ICU admission diagnoses of all 33 patients
Reason for ICU admittance
Elective cardiac surgery 9
Complications of prior cardiac surgery 3
Respiratory insufﬁciency 8
Endocarditis 2
Septic shock 2
Laparotomy for
Suspected perforation 1
Repair of ruptured aneurysm 1
Evacuation of infected hematoma 1
Trauma 1
Subarachnoid hemorrhage 1
Epileptic seizure 1
Hepatic failure 1
Cardiogenic shock 1
Hypovolemic shock 1
506exclude metastatic abscesses, showed FDG uptake in the
pericardium, suggestive of pericarditis. A pericardiocen-
tesis was performed after antibiotic treatment for 18 days,
but culture of the ﬂuid remained sterile. During follow-up,
this patient became afebrile, without clinical signs of
infective pericarditis. A FDG-PET/CT scan of another
patient with persistent fever, who had a single positive
blood culture with C. albicans 7 days prior to the FDG-
PET/CT scan and who was treated with anti-fungal ther-
apy, showed FDG uptake in the trochanteric bursa.
A consulted orthopedic surgeon did not ﬁnd clinical signs
of bursitis, and no further diagnostic tests were performed.
Although an infectious bursitis was not formally excluded,
the result of this FDG-PET/CT scan was also considered
false positive. The third false-positive patient was
Table 2 Diagnostic workup prior to PET/CT scan, ﬁnal diagnosis and correlation with PET/CT ﬁndings in all patients; in two patients (nos. 3 and 27) two
PET/CT scans were made
Patient Sex/
age
Indication
fo PET/
CT scan
Days on
ICU
Day of
fever
Cultures Cardiac
US
Vascular
US
CT scan Final
diagnosis
Mode of
diagnosis
PETCT
correlation
SBU
1 M/63 FUO 24 24 ?--- - - No infection - FP
2 M/50 Mediastinitis 12 11 ?--- - - Mediastinitis Biopsy TP
3a M/58 FUO 10 10 ??-- - Abdomen Phlebitis Culture TP
3b M/58 FUO 41 41 ??-- - - Pneumonia Culture TP
4 F/68 Mediastinitis 71 33 ?--? - - No infection - TN
5 M/63 Septic emboli 7 3 ??-- - Chest/abdomen Pneumonia Autopsy TP
6 M/71 FUO 34 31 ??-- - - No infection - TN
7 M/56 FUO 66 30 ?--? - Chest/abd/sinus No infection - TN
8 F/68 Septic emboli 2 - ---? - - Meningitis Culture TN
9 M/54 Septic emboli 27 7 ??-? - - Candida abscess Radiology TP
10 M/72 Mediastinitis 35 27 ?-?? - - No infection - TN
11 M/17 FUO 6 6 ???? ? - Dental abscess Culture TP
12 F/59 FUO 36 4 ?-?- - Chest No infection - TN
13 M/70 FUO 31 17 ?-?- - Sinus/chest/abd Prostatitis Culture TP
14 F/66 Septic emboli 4 - ?-?- - Chest/abdomen Arthritis Culture TP
15 M/50 Infected ﬂuid
collection
16 16 ?--- - Chest/abdomen Peritonitis Culture TP
16 M/58 Infected ﬂuid
collection
14 - ?--- - Chest/abdomen No infection - TN
17 M/42 Septic emboli 10 10 ?--? - - No infection - FP
18 M/68 SIRS 17 2 ?--- - - Pneumonia Radiology TP
19 M/51 FUO 20 28 ?--- - Head/chest Thyroid abscess Culture TP
20 M/37 FUO 27 26 ?-?- - - No infection - FP
21 F/68 FUO 17 11 ?--- - Head/abdomen No infection - TN
22 M/66 FUO 55 11 ?--? - - Sinusitis Culture TP
23 M/49 Septic emboli 22 12 ?--? - - Osteomyelitis Culture TP
24 F/69 Septic emboli 8 8 ?--? - - Infected hip
prosthesis
Culture TP
25 M/70 FUO 48 6 ?--- - - No infection Biopsy TN
26 M/35 FUO 12 27 ?--- ? Head/chest Sinusitis Clinical picture TP
27a M/59 SIRS 71 8 ?--? - - Pneumonia Radiology TP
27b M/59 SIRS 148 - ?-?- - - Leg abscess Culture TP
28 F/51 Septic emboli 21 20 ?-?- - - Candida abscess Radiology TP
29 M/1mo Septic
emboli
27 - ?-?- - Chest/
abdomen
No infection - TN
30 M/14 FUO 8 20 ?-?- - - Lymphoma Biopsy TP
31 M/1mo FUO 34 7 ?-?- - - Infected thrombus Radiology TP
32 F/1 FUO 20 14 ?-?- - Chest/abdomen No infection - TN
33 F/3 Septic emboli 28 23 ?-?- - - Candida abscess Culture TP
In all patients, blood cultures and chest X-rays were taken. A ? sign denotes
that the speciﬁed test was performed, the - sign that the speciﬁed test was
not been performed. In all patients blood cultures and a chest X-ray were
performed, but are not depicted in the table. S sputum, B broncho-alveolar
ﬂuid, U urine, US ultrasound, TP true positive, TN true negative, FP false
positive FN false negative
Table 3 4 9 4 diagram of FDG-PET/CT results compared to
follow-up
Follow-up? Follow-up- Total
FDG-PET/CT? 21 3 24
FDG-PET/CT- 01 11 1
Total 21 14 35
507admitted to the ICU with a subarachnoid hemorrhage and
had a FDG-PET/CT scan performed after 4 weeks of
spiking fever with repeated positive blood cultures with
coagulase-negative staphylococci, for which he was trea-
ted with teicoplanin for more than 2 weeks. The FDG-
PET/CT scan showed abnormal FDG uptake consistent
with an infected thrombus in the internal jugular vein with
signs of inﬂamed lymph nodes in the surrounding tissues.
Teicoplanin was stopped 3 days hereafter, and the patient
was discharged from the ICU 2 days later. In the 4 weeks
Fig. 1 This 17-year-old male with sickle cell trait was admitted to
the ICU because of sepsis. He was treated with piperacilline/
tazobactam, and blood cultures grew Streptococcus milleri. After
9 days, a FDG-PET/CT scan was performed because of persistent
fever, which showed increased FDG uptake in the right mandible,
suspect for a dental abscess. A dental surgeon subsequently
conﬁrmed a dental abscess, which was drained successfully, after
which the patient improved rapidly
Fig. 2 This 51-year-old patient
had recently received an
allogenic stem cell
transplantation because of
myelodysplastic syndrome. He
was admitted to the ICU with
respiratory failure. A FDG-
PET/CT scan was performed
after 3 weeks of ICU admission
because of fever that persisted
despite antibiotics and
antifungal treatment, showing
abnormal accumulation of the
tracer in the right thyroid lobe,
suggestive of an abscess.
A subsequent
hemithyroidectomy conﬁrmed
the presence of an abscess.
Cultures of this material
showed C. albicans
508of follow-up at the ward, fever gradually disappeared, and
the PET results were categorized as false positive. Based
on these results, sensitivity of FDG-PET was 100%,
speciﬁcity was 79%, positive predictive value was 88%
and negative predictive value was 100%. Overall accuracy
of the FDG-PET scans was 91%. The positive likelihood
ratio was 4.8, and the negative likelihood ratio was 0.
Solely based on biopsies and cultures, similar results were
obtained: sensitivity of 100%, a speciﬁcity of 78%, a PPV
of 84% and a NPV of 100%.
Discussion
In this clinical study we demonstrated the feasibility and
additional value of combined FDG-PET/CT scans in
ventilated critically ill patients. The high sensitivity and
speciﬁcity are promising, considering the fact that the
patients represent a subgroup of critically ill patients in
which the absence or presence of an infection could not
be obtained with conventional diagnostic procedures.
Naturally, identiﬁcation of the site of infection is essential
to institute the most appropriate therapy. The high spec-
iﬁcity of 79% indicates that in this small, highly selected
group of patients in whom no diagnosis could be reached
with conventional diagnostics, FDG-PET/CT scanning
appears to be of additional value in detecting focal
infection and inﬂammation. Although one may argue that,
e.g., sinusitis or pneumonia could be diagnosed by CT
alone, CT scans of the sinuses frequently show air-ﬂuid
levels whose clinical relevance is unclear, and chest CT
scans frequently show pulmonary abnormalities consis-
tent with atelectasis, pleural effusion and inﬁltrates in
ventilated ICU patients. In our opinion, the addition of
PET scanning to detect increased metabolism consistent
with inﬂammation in these lesions has additional value in
deciding whether or not the found abnormalities on the
CT scan are actually regions of infection and the cause of
symptoms and signs of the patient.
The high negative predictive value is also of major
clinical importance to exclude a clinically important
infection and prevent patients from being treated with
antibiotics or undergoing unnecessary invasive proce-
dures. As a measure of the post-test probability compared
to the estimated pre-test probability of an infection the
positive and negative likelihood ratio was calculated,
showing that the FDG-PET/CT scan is of evident addi-
tional clinical value to indicate and exclude patients with
the disease.
Up to now, scintigraphic imaging has played a very
limited role in detecting suspected focal infections in ICU
patients, as only two ICU case series are available in the
literature. In a retrospective study, Kao et al. [20] inves-
tigated the value of Tc-99m labeled leucocyte-
scintigraphy in detecting a source for occult sepsis in 25
ICU patients, demonstrating a sensitivity of 96% and a
speciﬁcity of 84%. However, sensitivity and speciﬁcity
were not calculated per patient, but per body region,
resulting in more true negative sites and thus a higher
speciﬁcity. Minoja et al. [21] prospectively evaluated the
use of Tc-99m-labeled leukocyte scintigraphy in detecting
the cause of occult sepsis in a group of 26 surgical and
trauma patients and found a sensitivity and speciﬁcity of
95 and 91%, respectively. It is important to note that
scintigraphic scans using Ga-67, In-111-labeled or
Tc-99m labeled leukocytes have disadvantages, such as
the amount of blood needed to harvest enough leukocytes
(up to 120 ml), handling of potentially infected blood
products, high radiation burden, and the long time span
between injection and diagnosis. Advantages of FDG-
PET are higher resolution, sensitivity in chronic low-
grade infections and high accuracy in the central skeleton
[22]. Furthermore, the time between FDG-injection and
diagnosis is approximately 1 h, so results are available
much sooner than in case of other nuclear medicine
techniques.
Our study is limited by several factors. First, in some
cases there was a speciﬁc suspicion of a localized infec-
tion, possibly increasing the a priori chance of an
infection. However, we chose to describe the daily stan-
dard practice in this observational study, thereby
accepting the differences in indications of PET/CT
scanning. Second, a ﬁnal diagnosis could not be estab-
lished in all patients. This is especially important in the
group of patients with negative FDG-PET/CT scans, since
missing a diagnosis of focal infection can have serious
consequences. Nevertheless, in none of the 11 patients
with a negative FDG-PET/CT scan was a subsequent
infectious diagnosis reached. When additional diagnostic
procedures showed normal results and follow-up did not
reveal a diagnosis, in the absence of a real gold standard,
it seemed reasonable to presume that a focal infection
with therapeutic consequences was not the cause of the
signs or symptoms of the patient. However, several
patients with normal FDG-PET/CT scans did receive
Table 4 Diagnostic methods establishing the ﬁnal infectious
diagnosis
Diagnostic method No. of cases
FDG-PET/CT
abnormal
FDG-PET/CT
scan normal
Deﬁnite
Culture or serology 12 1
Biopsy 2 1
Autopsy 1 –
Probable
Radiology 5 –
Clinical picture 1
509short courses of antibiotic treatment, so the presence of an
infection cannot be ruled out completely. In addition,
some of the patients with a normal FDG-PET/CT scan
developed an infectious complication more than 2 weeks
later during their ICU stay. It is difﬁcult to exactly
determine whether these infectious processes could have
been present at the time of the FDG-PET/CT scan.
However, because of the fact that all other diagnostic tests
performed at the time of the FDG-PET/CT scans in these
patients were also normal, we considered it unlikely that
these infections were present at the time of the FDG-PET/
CT scan, and we considered these FDG-PET/CT scans
true negative when no focal infection was diagnosed in
the 2 weeks following the scan. Despite these limitations,
our results indicate that a normal FDG-PET/CT scan
excludes an important infectious process needing drain-
age or prolonged antibiotic treatment. To our knowledge,
this is the ﬁrst study evaluating the additional value of
FDG-PET/CT scanning in diagnosing focal infections in
ventilated critically ill patients. In accordance, studies
evaluating PET scanning in diagnosing FUO in non-
critically ill patients showed comparable results [14–16,
23–25]. Our group previously and more speciﬁcally
investigated the role of FDG-PET in a subgroup of 48
non-critically ill, hospitalized patients with a suspected
focal infection or inﬂammatory disease and found that 38
out of 55 FDG-PET scans were abnormal, of which 36
correctly pointed to the cause of the symptoms. In addi-
tion, a negative predictive value of 100% was found [16].
These ﬁndings indicate that in both non-ICU as well as
critically ill ICU patients a negative PET/CT scan appears
to exclude a focal infection almost certainly as a cause of
the clinical symptoms.
In conclusion, our experience demonstrates the feasi-
bility and potential value of the FDG-PET/CT scan, and it
appears to be a promising tool in detecting and excluding
focal infection in critically ill patients. Since the exact
role of FDG-PET/CT scanning in critically ill ICU
patients is yet undeﬁned, we have to be vigilant to
potential hazardous additional diagnostic consequences of
the results of this technique. Nevertheless, the patient that
underwent a pericardiocenthesis that turned out to be
negative was the only case of the study where an addi-
tional invasive procedure was performed with a clear
detrimental risk/beneﬁt ratio. In this speciﬁc case the
decision to perform a pericardiocenthesis was not only
based on the results of the FDG-PET/CT scan, but also on
the results of echocardiography. In the other 13 patients
with a positive FDG-PET/CT scan, subsequent diagnostic
tests resulted in the ﬁnal diagnosis.
We propose that the use of the FDG-PET/CT scan
should be considered earlier in critically ill patients sus-
pected of an infection. Whether FDG-PET/CT scanning
can be of additional value in the early detection of speciﬁc
types of focal infection notoriously difﬁcult to diagnose
(e.g., mediastinitis, metastatic abscesses) will be the
subject of future research.
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